A Phase I/II Trial of 5-Fluorouracil and Etoposide in Metastatic Colorectal Carcinoma

A Phase I Study of Cisplatinum plus 5-Fluorouracil in Modulation with Citrovorum Factor in Metastatic Colorectal Carcinoma

Journal of Chemotherapy ◽

10.1080/1120009x.1991.11739087 ◽

1991 ◽

Vol 3 (3) ◽

pp. 170-175 ◽

Cited By ~ 1

Author(s):

S. Palmeri ◽

V. Gebbia ◽

A. Russo ◽

N. Gebbia ◽

Y. Rustum ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Phase I Study ◽

Abstract CT216: Phase I/IIa non-randomized open-label trials with mouse renal adenocarcinoma (RENCA) cell containing agarose-agarose macrobeads in patients with treatment-resistant metastatic colorectal carcinoma

10.1158/1538-7445.am2015-ct216 ◽

2015 ◽

Author(s):

Allyson J. Ocean ◽

Nathaniel Berman ◽

Tapan Parikh ◽

Zoe P. Andrada ◽

Angelica Nazarian ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Treatment Resistant ◽

Open Label ◽

Renal Adenocarcinoma

Active Specific Immunotherapy for Metastatic Colorectal Carcinoma: Phase I Study of an Allogeneic Cell Vaccine Plus Low-Dose Interleukin-1??

Journal of Immunotherapy ◽

10.1097/00002371-199905000-00008 ◽

1999 ◽

Vol 22 (3) ◽

pp. 251-259 ◽

Cited By ~ 21

Author(s):

Timothy J. Woodlock ◽

Deepak M. Sahasrabudhe ◽

Diana M. Marquis ◽

Dori Greene ◽

Kishan J. Pandya ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Phase I Study ◽

Low Dose ◽

Specific Immunotherapy ◽

Interleukin 1 ◽

Cell Vaccine ◽

Allogeneic Cell ◽

Active Specific Immunotherapy

Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver

Human Gene Therapy ◽

10.1089/hum.2006.17.1214 ◽

2006 ◽

Vol 17 (12) ◽

pp. 1214-1224 ◽

Cited By ~ 112

Author(s):

Nancy Kemeny ◽

Karen Brown ◽

Anne Covey ◽

Teresa Kim ◽

Amit Bhargava ◽

...

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Colorectal Carcinoma ◽

Phase I ◽

Genetically Engineered ◽

Open Label ◽

Label Dose ◽

Simplex Virus ◽

Dose Escalating

Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver

Human Gene Therapy ◽

10.1089/hum.2006.17.ft-262 ◽

2006 ◽

Vol 0 (0) ◽

pp. 061115103131001

Author(s):

Nancy Kemeny ◽

Karen Brown ◽

Anne Covey ◽

Teresa Kim ◽

Amit Bhargava ◽

...

Keyword(s):

Herpes Simplex Virus ◽

Herpes Simplex ◽

Colorectal Carcinoma ◽

Phase I ◽

Genetically Engineered ◽

Open Label ◽

Label Dose ◽

Simplex Virus ◽

Dose Escalating

A Phase I, first-in-human, open label, dose escalation study of MGD007, a humanized gpA33 × CD3 dual-affinity re-targeting (DART®) protein in patients with relapsed/refractory metastatic colorectal carcinoma

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-2-s3-p86 ◽

2014 ◽

Vol 2 (Suppl 3) ◽

pp. P86 ◽

Cited By ~ 7

Author(s):

Herbert Hurwitz ◽

Todd Crocenzi ◽

Joanna Lohr ◽

Ezio Bonvini ◽

Syd Johnson ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Dose Escalation ◽

Open Label ◽

Dose Escalation Study ◽

Label Dose

Phase I study of 5-FU and arsenic trioxide (ATO) in patients with refractory metastatic colorectal carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e14081 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e14081-e14081

Author(s):

B. Ardalan ◽

P. R. Subbarayan ◽

Y. Ramos ◽

M. Gonzalez ◽

D. Mezentsev ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Arsenic Trioxide ◽

Phase I Study ◽

A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma

Cancer ◽

10.1002/1097-0142(19920215)69:4<889::aid-cncr2820690409>3.0.co;2-r ◽

1992 ◽

Vol 69 (4) ◽

pp. 889-892 ◽

Cited By ~ 13

Author(s):

Ronald M. Bukowski ◽

Go Inoshita ◽

Prasad Yalavarthi ◽

Siva Murthy ◽

Vicki Gibson ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Folinic Acid ◽

Phase I Trial ◽

A phase I trial of 5-fluorouracil, leucovorin and interferon-α2b administered by 24 h infusion in metastatic colorectal carcinoma

Anti-Cancer Drugs ◽

10.1097/00001813-199607000-00004 ◽

1996 ◽

Vol 7 (5) ◽

pp. 520-524 ◽

Cited By ~ 1

Author(s):

Stefano Cascinu ◽

Elena Del Ferro ◽

Marco Ligi ◽

Giuseppina Catalano

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Phase I Trial ◽

Interferon Α2b

A phase I–II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma

European Journal of Cancer ◽

10.1016/0959-8049(92)90141-n ◽

1992 ◽

Vol 28 (4-5) ◽

pp. 885-888 ◽

Cited By ~ 4

Author(s):

Harm A.M. Sinnige ◽

Afien G. Nanninga ◽

Rene C.J. Verschueren ◽

Dirk Th. Sleijfer ◽

Elisabeth G.E. de Vries ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase I ◽

Continuous Infusion ◽

Weekly Bolus